Luke L. McGoldrick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Luke L. McGoldrick has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Jee Hae Kim
Regeneron Pharmaceuticals, Inc., Tarrytown, USA
2 shared publicationsJo-Hao Ho
Regeneron Pharmaceuticals, Inc., Tarrytown, USA
2 shared publications- Kei Saotome
Regeneron Pharmaceuticals, Inc., Tarrytown, USA
2 shared publications - Matthew C. Franklin
Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA
2 shared publications Michael J. Moore
Regeneron Pharmaceuticals, Inc., Tarrytown, USA
2 shared publicationsRaymond Leidich
Regeneron Pharmaceuticals, Inc., Tarrytown, USA
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 23 September 2024
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 32 (2) , 315-325
Structural insights into CXCR4 modulation and oligomerization
Activation of the chemokine receptor CXCR4 by its chemokine ligand CXCL12 regulates diverse cellular processes. Previously reported crystal structures of CXCR4 revealed the architecture of an inactive, homodimeric receptor. However, many structural aspects of CXCR4 remain poorly understood. Here, we use cryo-electron microscopy to investigate various modes of human CXCR4 regulation. CXCL12 activates CXCR4 by inserting its N terminus deep into the CXCR4 orthosteric pocket. The binding of US Food and Drug Administration-approved antagonist AMD3100 is stabilized by electrostatic interactions with acidic residues in the seven-transmembrane-helix bundle. A potent antibody blocker, REGN7663, binds across the extracellular face of CXCR4 and inserts its complementarity-determining region H3 loop into the orthosteric pocket. Trimeric and tetrameric structures of CXCR4 reveal modes of G-protein-coupled receptor oligomerization. We show that CXCR4 adopts distinct subunit conformations in trimeric and tetrameric assemblies, highlighting how oligomerization could allosterically regulate chemokine receptor function.
- 23 September 2024
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 32 (2) , 315-325
Top Cited PapersOpen AccessStructural insights into CXCR4 modulation and oligomerization
Activation of the chemokine receptor CXCR4 by its chemokine ligand CXCL12 regulates diverse cellular processes. Previously reported crystal structures of CXCR4 revealed the architecture of an inactive, homodimeric receptor. However, many structural aspects of CXCR4 remain poorly understood. Here, we use cryo-electron microscopy to investigate various modes of human CXCR4 regulation. CXCL12 activates CXCR4 by inserting its N terminus deep into the CXCR4 orthosteric pocket. The binding of US Food and Drug Administration-approved antagonist AMD3100 is stabilized by electrostatic interactions with acidic residues in the seven-transmembrane-helix bundle. A potent antibody blocker, REGN7663, binds across the extracellular face of CXCR4 and inserts its complementarity-determining region H3 loop into the orthosteric pocket. Trimeric and tetrameric structures of CXCR4 reveal modes of G-protein-coupled receptor oligomerization. We show that CXCR4 adopts distinct subunit conformations in trimeric and tetrameric assemblies, highlighting how oligomerization could allosterically regulate chemokine receptor function.
- Open Access
Structural insights into CXCR4 modulation and oligomerization
Activation of the chemokine receptor CXCR4 by its chemokine ligand CXCL12 regulates diverse cellular processes. CXCR4 also serves as a key target for diseases such as cancer and HIV. Previously reported crystal structures of CXCR4 bound to antagonists revealed the architecture of an inactive, homodimeric receptor. However, many structural aspects of CXCR4 remain poorly understood, including its activation by CXCL12, as well as its assembly into higher-order oligomers. Here, we use cryoelectron microscopy (cryoEM) to investigate various modes of CXCR4 regulation in the presence and absence of G i protein. CXCL12 activates CXCR4 by inserting its N-terminus deep into the CXCR4 orthosteric pocket. The binding of FDA-approved antagonist AMD3100 is stabilized by electrostatic interactions with acidic residues in the 7 transmembrane helix bundle. A potent antibody blocker, REGN7663, binds across the extracellular face of CXCR4 and inserts its CDR-H3 loop into the orthosteric pocket. Trimeric and tetrameric structures of CXCR4 reveal, to our knowledge, previously undescribed modes of GPCR oligomerization. Remarkably, CXCR4 adopts distinct subunit conformations in trimeric and tetrameric assemblies, highlighting how oligomerization could allosterically regulate chemokine receptor function.
Open AccessStructural insights into CXCR4 modulation and oligomerization
Activation of the chemokine receptor CXCR4 by its chemokine ligand CXCL12 regulates diverse cellular processes. CXCR4 also serves as a key target for diseases such as cancer and HIV. Previously reported crystal structures of CXCR4 bound to antagonists revealed the architecture of an inactive, homodimeric receptor. However, many structural aspects of CXCR4 remain poorly understood, including its activation by CXCL12, as well as its assembly into higher-order oligomers. Here, we use cryoelectron microscopy (cryoEM) to investigate various modes of CXCR4 regulation in the presence and absence of G i protein. CXCL12 activates CXCR4 by inserting its N-terminus deep into the CXCR4 orthosteric pocket. The binding of FDA-approved antagonist AMD3100 is stabilized by electrostatic interactions with acidic residues in the 7 transmembrane helix bundle. A potent antibody blocker, REGN7663, binds across the extracellular face of CXCR4 and inserts its CDR-H3 loop into the orthosteric pocket. Trimeric and tetrameric structures of CXCR4 reveal, to our knowledge, previously undescribed modes of GPCR oligomerization. Remarkably, CXCR4 adopts distinct subunit conformations in trimeric and tetrameric assemblies, highlighting how oligomerization could allosterically regulate chemokine receptor function.
- Open Access
- 27 February 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Stopping sperm in their tracks
An automated high-throughput platform can screen for molecules that change the motility of sperm cells and their ability to fertilize.
- 27 February 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Open AccessStopping sperm in their tracks
An automated high-throughput platform can screen for molecules that change the motility of sperm cells and their ability to fertilize.
- Open Access
- 3 August 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 4 (8) , eaau6088
Mechanism of calmodulin inactivation of the calcium-selective TRP channel TRPV6
Cryo-EM structures of the epithelial calcium channel TRPV6-calmodulin complex reveal a mechanism of Ca 2+ -induced inactivation.
- 3 August 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 4 (8) , eaau6088
Open AccessMechanism of calmodulin inactivation of the calcium-selective TRP channel TRPV6
Cryo-EM structures of the epithelial calcium channel TRPV6-calmodulin complex reveal a mechanism of Ca 2+ -induced inactivation.